PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 3, 2010Journal of Internal Medicine249 citations

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up

View Full Paper
ALAnne LangstedJFJ FreibergATAnne Tybjærg‐Hansen

Structured PICO

Do high levels of nonfasting cholesterol and triglycerides increase the risk of myocardial infarction and total mortality in the general population?

P
Population
13,972 individuals (7,581 women and 6,391 men) randomly selected from the Danish general population, with less than 2% taking lipid-lowering therapy.
I
Intervention
High levels of nonfasting cholesterol and triglycerides
C
Comparator
Low levels of nonfasting cholesterol (<5 mmol/L) and nonfasting triglycerides (<1 mmol/L)
O
Outcome
Myocardial infarction and total mortalityhard clinical

Stepwise increases in nonfasting triglycerides are strongly associated with both myocardial infarction and total mortality, whereas nonfasting cholesterol predicts myocardial infarction but not total mortality.

Abstract

OBJECTIVES: We compared the ability of very high levels of nonfasting cholesterol and triglycerides to predict risk of myocardial infarction and total mortality. DESIGN: Prospective study from 1976 to 1978 until 2007. SETTING: Danish general population. PARTICIPANTS: Randomly selected population of 7581 women and 6391 men, of whom 768 and 1151 developed myocardial infarction and 4398 and 4416 died, respectively. Participation rate was 72%, and follow-up was 100% complete. Less than 2% of participants were taking lipid-lowering therapy. RESULTS: Compared to women with cholesterol <5 mmol L(-1) , multivariate-adjusted hazard ratios for myocardial infarction ranged from 1.3 95% confidence interval (CI): 0.9-1.8 for a cholesterol level of 5.0-5.99 mmol L(-1) to 2.5 (95%CI: 1.6-4.0) for cholesterol ≥ 9 mmol L(-1) (trend: P < 0.0001). Compared with women with nonfasting triglycerides <1 mmol L(-1) , hazard ratios for myocardial infarction ranged from 1.5 (95%CI: 1.2-1.8) for triglycerides of 1.0-1.99 mmol L(-1) to 4.2 (95%CI: 2.5-7.2) for triglycerides ≥ 5 mmol L(-1) (p<0.0001). In men, corresponding hazard ratios ranged from 1.2 (95%CI: 1.0-1.5) to 5.3 (95%CI: 3.6-8.0) for cholesterol (P < 0.0001) and from 1.3 (95%CI: 1.0-1.6) to 2.1 (95%CI: 1.5-2.8) for triglycerides (P < 0.0001). Increasing cholesterol levels were not consistently associated with total mortality in women (trend: P = 0.39) or men (P = 0.02). By contrast, compared with women with triglycerides <1 mmol L(-1) , multivariate-adjusted hazard ratios for total mortality ranged from 1.1 (95%CI: 1.0-1.2) for triglycerides of 1.0-1.99 mmol L(-1) to 2.0 (95%CI: 1.5-2.9) for triglycerides ≥5 mmol L(-1) (trend: P < 0.0001); corresponding hazard ratios in men ranged from 1.1 (95%CI: 1.0-1.2) to 1.5 (95%CI: 1.2-1.7) (P < 0.0001). CONCLUSIONS: Stepwise increasing levels of nonfasting cholesterol and nonfasting triglycerides were similarly associated with stepwise increasing risk of myocardial infarction, with nonfasting triglycerides being the best predictor in women and nonfasting cholesterol the best predictor in men. Even more surprisingly, only increasing levels of nonfasting triglycerides were associated with total mortality, whereas increasing cholesterol levels were not.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Langsted et al. (2010) studied this question.

synapsesocial.com/papers/6a100c8d96ccf432805fe990https://doi.org/10.1111/j.1365-2796.2010.02333.x
Ask AI
Helpful
Bookmark
Share
View Full Paper